MedPath

Prospective Liver Study

Completed
Conditions
Liver Cancer
Registration Number
NCT01539993
Lead Sponsor
Emory University
Brief Summary

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients diagnosed with Hepatocellular carcinoma and referred for percutaneous liver treatment.
Read More
Exclusion Criteria
  • Severe liver disfunction
  • Active uncontrolled infection
  • Significant underlying medical of physical illness
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assess efficacy of percutaneous and transarterial treatments for liver cancer.1 month

QOL questionnaire will be collected during follow up visit.

Secondary Outcome Measures
NameTimeMethod
long term follow up3 months, 6 months 1year

Patients will be administered QOL during 3 months, 6 months and 1 year follow up.

Trial Locations

Locations (1)

Emory University

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath